Aurora A kinase has been shown to stabilise MYCN [22] and early results in preclinical models have proven promising with data suggesting that MLN8237 might reduce MYCN protein levels, decrease cell proliferation and increase differentiation of Neuroblastoma cells [23, 24]. Here, MYCN is linked to neuroblastoma.